retatrutide joint pain Achieves Up to 28.7% Weight Loss and Marked Knee Reduction in Phase 3 TRIUMPH-4 Trial Retatrutide Sets New Benchmark in

Mark Hyman partners with Levels to solve the metabolic health crisis

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.

Its in good form.

importante destacar que PHYSIOMANCE GLP-1 Protect de forma alguma substitui os tratamentos com agonistas GLP-1 e GIP

GLP-1 medications may help block inflammatory lung scarring and damage from COVID-19 in people with diabetes and reduce long COVID risk, a new study finds.

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA